Lyn regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells. Specifically, Lyn is involved in the EGFR signaling pathway, and inhibition of its expression can reduce EGFR activation and cell viability [123]. Here, EGFR is linked to lung adenocarcinoma.